MX374852B - Procesos para la preparacion de compuestos de pirimidinilciclopentano - Google Patents

Procesos para la preparacion de compuestos de pirimidinilciclopentano

Info

Publication number
MX374852B
MX374852B MX2019006959A MX2019006959A MX374852B MX 374852 B MX374852 B MX 374852B MX 2019006959 A MX2019006959 A MX 2019006959A MX 2019006959 A MX2019006959 A MX 2019006959A MX 374852 B MX374852 B MX 374852B
Authority
MX
Mexico
Prior art keywords
preparation
sup
flexible substrate
wearable
useful
Prior art date
Application number
MX2019006959A
Other languages
English (en)
Other versions
MX2019006959A (es
Inventor
Francis Gosselin
Hans Iding
Michelangelo Scalone
Reinhard Reents
Original Assignee
Hoffmann La Roche
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Genentech Inc filed Critical Hoffmann La Roche
Publication of MX2019006959A publication Critical patent/MX2019006959A/es
Publication of MX374852B publication Critical patent/MX374852B/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/02Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from isocyanates with formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/165Heterorings having nitrogen atoms as the only ring heteroatoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La presente invención se relaciona con un proceso para la preparación de un compuesto de fórmula (I), donde R1 es como se define en la presente, que es útil como un intermediario en la preparación de los compuestos farmacéuticos activos.
MX2019006959A 2013-11-15 2014-11-13 Procesos para la preparacion de compuestos de pirimidinilciclopentano MX374852B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13193030 2013-11-15
PCT/US2014/065567 WO2015073739A1 (en) 2013-11-15 2014-11-13 Processes for the preparation of pyrimidinylcyclopentane compounds

Publications (2)

Publication Number Publication Date
MX2019006959A MX2019006959A (es) 2019-08-01
MX374852B true MX374852B (es) 2025-03-06

Family

ID=49582648

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2016006299A MX367620B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.
MX2019006959A MX374852B (es) 2013-11-15 2014-11-13 Procesos para la preparacion de compuestos de pirimidinilciclopentano
MX2020009462A MX385726B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016006299A MX367620B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2020009462A MX385726B (es) 2013-11-15 2014-11-13 Procesos para la preparación de compuestos de pirimidinilciclopentano.

Country Status (21)

Country Link
US (3) US9862689B2 (es)
EP (3) EP3068770B1 (es)
JP (4) JP6374503B2 (es)
KR (2) KR102698200B1 (es)
CN (3) CN105899492B (es)
AR (1) AR098427A1 (es)
AU (5) AU2014348570B2 (es)
CA (2) CA2930870C (es)
ES (2) ES2765511T3 (es)
HR (2) HRP20231100T1 (es)
HU (1) HUE063095T2 (es)
IL (3) IL245636B (es)
MX (3) MX367620B (es)
MY (2) MY174153A (es)
NZ (1) NZ720805A (es)
PL (2) PL3068770T3 (es)
RU (1) RU2702355C1 (es)
SG (1) SG10201901578UA (es)
SI (1) SI3068770T1 (es)
WO (1) WO2015073739A1 (es)
ZA (2) ZA201603434B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2930870C (en) 2013-11-15 2023-09-19 F. Hoffmann-La Roche Ag Processes for the preparation of pyrimidinylcyclopentane compounds
KR102513869B1 (ko) 2014-09-26 2023-03-23 에프. 호프만-라 로슈 아게 (시클로펜틸[d]피리미딘-4-일)피페라진 화합물의 제조 방법
KR102766096B1 (ko) 2016-08-10 2025-02-12 에프. 호프만-라 로슈 아게 Akt 단백질 키나아제 저해제를 포함하는 약학 조성물
GB201802383D0 (en) * 2018-02-14 2018-03-28 Givaudan Sa Process

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6545165B1 (en) 2000-02-04 2003-04-08 Roche Colorado Corporation Synthesis of 3,6-dialkyl-5,6-dihydro-4-hydroxy-pyran-2-one
KR100927910B1 (ko) * 2005-05-24 2009-11-19 에프. 호프만-라 로슈 아게 (s)-4-플루오로메틸-다이하이드로-퓨란-2-온의 제조
CN101198594A (zh) * 2005-06-22 2008-06-11 尼科梅德有限责任公司 用于制备生产三环苯并咪唑类的中间体的方法
KR101527232B1 (ko) * 2006-07-06 2015-06-09 어레이 바이오파마 인크. Akt 단백질 키나제 억제제로서의 시클로펜타〔d〕피리미딘
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
US7977078B2 (en) 2007-08-24 2011-07-12 Codexis, Inc. Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane
KR101624753B1 (ko) * 2008-01-09 2016-05-26 어레이 바이오파마 인크. Akt 단백질 키나제 저해물질로서의 수산화된 피리미딜 시클로펜탄
KR101624752B1 (ko) * 2008-01-09 2016-05-26 어레이 바이오파마 인크. Akt 단백질 키나제 저해물질로써의 수산화된 피리미딜 시클로펜탄
AR070176A1 (es) * 2008-01-17 2010-03-17 Novartis Ag Procesos de sintesis de inhibidores de nep, compuestos intermediarios y uso de los mismos en la sintesis
US8426178B2 (en) 2008-08-27 2013-04-23 Codexis, Inc. Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine
CN102186972B (zh) 2008-08-29 2014-08-20 科德克希思公司 用于立体选择性生产(4s)-3-[(5s)-5-(4-氟苯基)-5-羟基戊酰基]-4-苯基-1,3-噁唑烷-2-酮的酮还原酶多肽
US20110054174A1 (en) * 2009-08-28 2011-03-03 Stephan Bachmann Process for the preparation of a glucokinase activator compound
JP2013528787A (ja) * 2010-04-16 2013-07-11 ジェネンテック, インコーポレイテッド Pi3k/aktキナーゼ経路インヒビターの効果の予測バイオマーカーとしてのfox03a
KR20140025434A (ko) * 2011-04-01 2014-03-04 제넨테크, 인크. Akt 억제제 화합물 및 화학요법제의 조합물, 및 사용 방법
MY169029A (en) * 2012-05-17 2019-02-04 Genentech Inc Process of making hydroxylated cyclopentapyrimidine compounds and salts thereof
PL2861583T3 (pl) 2012-05-17 2016-12-30 Sposób wytwarzania hydroksylowanych związków cyklopentylopirymidyny
MA37751B1 (fr) * 2012-05-17 2018-08-31 Genentech Inc Procédé de préparation de composés d'acides aminés
BR112014028589B1 (pt) * 2012-05-17 2022-08-23 Genentech, Inc. Ciclopentilpirimidina hidroxilada, seu processo de fabricação e seus intermediários
KR20200074252A (ko) * 2012-05-17 2020-06-24 제넨테크, 인크. 무정형 형태의 akt 저해성 피리미디닐 - 사이클로펜탄 화합물, 조성물 및 이들의 방법
CA2930870C (en) 2013-11-15 2023-09-19 F. Hoffmann-La Roche Ag Processes for the preparation of pyrimidinylcyclopentane compounds
KR102513869B1 (ko) 2014-09-26 2023-03-23 에프. 호프만-라 로슈 아게 (시클로펜틸[d]피리미딘-4-일)피페라진 화합물의 제조 방법

Also Published As

Publication number Publication date
CN105899492B (zh) 2021-08-24
KR102493603B1 (ko) 2023-01-31
IL245636B (en) 2019-12-31
HUE063095T2 (hu) 2023-12-28
ES2957314T3 (es) 2024-01-17
CA2930870A1 (en) 2015-05-21
ES2765511T3 (es) 2020-06-09
EP3068770B1 (en) 2019-10-23
WO2015073739A1 (en) 2015-05-21
KR102698200B1 (ko) 2024-08-26
CN105899492A (zh) 2016-08-24
AU2014348570B2 (en) 2019-02-28
CN110590606B (zh) 2023-02-17
US20160297773A1 (en) 2016-10-13
SI3068770T1 (sl) 2020-02-28
JP2016539939A (ja) 2016-12-22
AR098427A1 (es) 2016-05-26
MX367620B (es) 2019-08-28
ZA201603434B (en) 2020-08-26
AU2014348570A1 (en) 2016-06-09
JP2021100953A (ja) 2021-07-08
AU2024205845A1 (en) 2024-09-05
EP3656764A1 (en) 2020-05-27
CN110590606A (zh) 2019-12-20
IL281072A (en) 2021-04-29
MY191759A (en) 2022-07-14
JP2018052966A (ja) 2018-04-05
IL281072B (en) 2022-05-01
KR20220139440A (ko) 2022-10-14
EP3656764C0 (en) 2023-07-05
HRP20192340T1 (hr) 2020-04-03
RU2019130505A (ru) 2020-02-18
US10858324B2 (en) 2020-12-08
JP6374503B2 (ja) 2018-08-15
MX2020009462A (es) 2021-08-31
EP3656764B1 (en) 2023-07-05
KR20160075816A (ko) 2016-06-29
CN112898210B (zh) 2025-02-21
AU2019202461A1 (en) 2019-05-02
US10435378B2 (en) 2019-10-08
US20180086722A1 (en) 2018-03-29
BR112016011048A8 (pt) 2020-04-22
MX2016006299A (es) 2017-02-22
CN112898210A (zh) 2021-06-04
EP3068770A1 (en) 2016-09-21
IL271331B (en) 2021-03-25
AU2022275477A1 (en) 2023-01-05
JP7377828B2 (ja) 2023-11-10
PL3068770T3 (pl) 2020-04-30
RU2016123365A (ru) 2017-12-18
EP4282973A3 (en) 2024-03-27
AU2019202461B2 (en) 2021-01-14
EP3068770A4 (en) 2017-04-19
PL3656764T3 (pl) 2024-01-22
AU2021202196A1 (en) 2021-05-06
MX2019006959A (es) 2019-08-01
JP2019218384A (ja) 2019-12-26
NZ720805A (en) 2022-01-28
IL245636A0 (en) 2016-06-30
ZA202002611B (en) 2023-10-25
HRP20231100T1 (hr) 2023-12-22
IL271331A (en) 2020-01-30
US20200062717A1 (en) 2020-02-27
MY174153A (en) 2020-03-11
JP6857219B2 (ja) 2021-04-14
RU2702355C1 (ru) 2019-10-08
BR112016011048A2 (pt) 2017-08-08
SG10201901578UA (en) 2019-03-28
US9862689B2 (en) 2018-01-09
CA2930870C (en) 2023-09-19
CA3207199A1 (en) 2015-05-21
JP6634428B2 (ja) 2020-01-22
EP4282973A2 (en) 2023-11-29
MX385726B (es) 2025-03-18
HK1223102A1 (zh) 2017-07-21

Similar Documents

Publication Publication Date Title
WO2014052506A3 (en) Facilitating affective feedback using wearable computing devices
WO2015108601A3 (en) Vibration energy compensation for a skin surface microphone ("ssm") in wearable communication devices
PH12015501082A1 (en) Pyridine -2-amides useful as cb2 agonists
MX374852B (es) Procesos para la preparacion de compuestos de pirimidinilciclopentano
WO2014152055A3 (en) Sensing physiological characteristics with ear-related devices
PH12014501597A1 (en) Hand-held device for electrically assisted dermal treatment
PL410261A1 (pl) Urządzenie do elektroprodukcji lub elektrorafinacji materiału
IN2014DN08965A (es)
SMT201700235T1 (it) Schema universale adattativo ed estensibile per dispositivi internet delle cose (iot) eterogenei
MY157390A (en) Switching circuit and semiconductor module
EP2634809A3 (en) Field effect transistor
TWD167754S (zh) 電路連接器(二)
WO2014195482A3 (en) Organic electronic device
WO2011103952A8 (en) Electrode treatment process for organic electronic devices
JP1719683S (ja) 電気コネクタ
WO2012114306A3 (en) Feedthrough having a non-linear conductor
JP1719731S (ja) 電気コネクタ
GB201008492D0 (en) An antenna
NZ711191A (en) Benzo-fused heterocyclic derivatives useful as agonists of gpr120
BR112015030249A2 (pt) eletrodo médico, e garra de membro para um dispositivo ecg
TWD164746S (zh) 電連接器
PH12016500226A1 (en) Electronic circuit connecting structure
JP2014179314A5 (es)
JP1722305S (ja) 電気コネクタ
EP3874564A4 (en) HEAT DISSIPATION FROM PLUGS-CONNECTED ACTIVE DEVICES

Legal Events

Date Code Title Description
FG Grant or registration